Wegovy launch delayed in the UK
The launch of Wegovy has been delayed in the UK as manufacturer seeks to ensure guaranteed supply once roll-out starts
Wegovy - what's happening?
Building up supply
Wegovy - NHS implications
Wegovy was first licensed for with loss in the UK in September 2021.
The National Institute for Health and Care Excellence (Nice) announced in March of this year that Wegovy could be given to patients with a BMI over 30 and at least one condition such as high blood pressure. About four million people in England are expected to be eligible for the drug on the NHS when it launches. The drug, used by celebrities including Elon Musk and Kim Kardashian, mimics a hormone that makes people feel full and has helped people reduce weight by more than 15% in trials. It is given as a weekly injection and is already available in the UK under the brand name Ozempic as a treatment for diabetes. Some doctors will prescribe it off label for weight loss.
The launch of Wegovy in the UK has been highly anticipated by both pharmacists and obesity experts with NHS hospitals and private providers, such as CheqUp, gearing up for the launch.
The drug has been hailed as a "game changer" and is expected to help millions of eligible people in England.
Published: 04 May 2023